Table 2.
Prevalence of IFG and diabetes co-morbidity with CVD risk factors
| CVD risk factors | Proportion (N = 2447) | Prevalence (%) | 95% confidence interval | SE | |
|---|---|---|---|---|---|
| Lower | upper | ||||
| HBP | 566 | 23.1 | 21.5 | 24.8 | 0.8 |
| Hypercholesterolaemia | 634 | 25.9 | 24.2 | 27.7 | 0.9 |
| Hypertriglyceridaemia | 572 | 23.4 | 21.6 | 25.1 | 0.9 |
| Low HDL-C | 1073 | 43.8 | 41.8 | 45.7 | 1.0 |
| Overweight/obese | 979 | 40.0 | 38.0 | 42.1 | 1.0 |
| IFG | 141 | 5.8 | 4.9 | 6.7 | 0.5 |
| IFG + dyslipidaemia | 122 | 5.0 | 4.2 | 5.9 | 0.4 |
| IFG + HBP | 64 | 2.6 | 2.0 | 3.3 | 0.3 |
| IFG + overweight/obese | 76 | 3.1 | 2.5 | 3.8 | 0.4 |
| Diabetes | 76 | 3.1 | 2.4 | 3.8 | 0.4 |
| Diabetes + dyslipidaemia | 65 | 2.7 | 2.0 | 3.4 | 0.3 |
| Diabetes + HBP | 47 | 1.9 | 1.4 | 2.5 | 0.3 |
| Diabetes + overweight/obese | 48 | 2.0 | 1.4 | 2.6 | 0.3 |
IFG impaired fasting glucose, + with, HDL high density lipoprotein cholesterol, HBP high blood pressure, SE standard error